All
Quantoom Biosciences Launches Ntensify™ mano: A Groundbreaking kit for Rapid and Scalable mRNA Production
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreQuantoom Biosciences’ Ntensify™ Midi System Adopted by Bio-Manguinhos/Fiocruz Laboratory for Future Groundbreaking mRNA Vaccine Production in Latin America
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreA New Paradigm in mRNA Bioprocessing. How Ntensify™ Reshapes Affordability and Reduces Time-to-Market
Rabies mRNA Vaccine Download the case study as a pdf: Contact Us Please complete the form below for any commercial, partnering, media, press, or general inquiries. If you need to contact our customer service team, please click on the button below. Contact the customer service
Read MoreQuantoom Biosciences Prepares for the Implementation of the Ntensify™ Midi System by Afrigen Biologics’ in their GMP Facility, Paving the Way for African-Owned mRNA Vaccine Production
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreQuantoom Biosciences Collaborates with Stevanato Group to Elevate mRNA production with Nfinity™ Platform
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoremRNA Production Reinvented
mRNA Production Reinvented Download the Corporate presentation as a pdf: Contact Us Please complete the form below for any commercial, partnering, media, press, or general inquiries. If you need to contact our customer service team, please click on the button below. Contact the customer service
Read MoreQuantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreQuantoom expands U.S. Market Reach with Key Appointments
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreQuantoom Biosciences installs the first Ntensify™ system for mRNA manufacturing at Afrigen Biologics in Cape Town
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read MoreImmuneWatch, Quantoom Biosciences and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines
New agreement paves way for development of first African-owned COVID-19 vaccine.
Read More